Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Bollard

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Vox Sanguinis|June 24, 2004
Options for T-cell based therapiesH E Heslop, S M Gottschalk, C M Bollard, et al.
Annals of the New York Academy of Sciences|February 8, 2006
T-cell immunotherapy for adenoviral infections of stem-cell transplant recipientsA M Leen, G D Myers, C M Bollard, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
T cell therapiesS Gottschalk, C M Bollard, K C Straathof, et al.
Clinical and Experimental Immunology|March 5, 2016
Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humansA B Bigley, K Rezvani, N Shah, et al.
Leukemia|March 27, 2013
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantG Weber, U Gerdemann, I Caruana, et al.
Leukemia|December 2, 2015
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemiaR H Rouce, H Shaim, T Sekine, et al.
Leukemia & Lymphoma|April 7, 2010
Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institutionJ A Shafer, H E Heslop, M K Brenner, et al.
Clinical and Experimental Immunology|June 15, 2013
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapyC R Y Cruz, S Lam, P J Hanley, et al.
Pediatric Hematology and Oncology|May 29, 2012
Pediatric Hodgkin lymphoma: are we over-scanning our patients?N Rathore, H M Eissa, J F Margolin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Vox Sanguinis|June 24, 2004
Options for T-cell based therapiesH E Heslop, S M Gottschalk, C M Bollard, et al.
Annals of the New York Academy of Sciences|February 8, 2006
T-cell immunotherapy for adenoviral infections of stem-cell transplant recipientsA M Leen, G D Myers, C M Bollard, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
T cell therapiesS Gottschalk, C M Bollard, K C Straathof, et al.
Clinical and Experimental Immunology|March 5, 2016
Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humansA B Bigley, K Rezvani, N Shah, et al.
Leukemia|March 27, 2013
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantG Weber, U Gerdemann, I Caruana, et al.
Leukemia|December 2, 2015
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemiaR H Rouce, H Shaim, T Sekine, et al.
Leukemia & Lymphoma|April 7, 2010
Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institutionJ A Shafer, H E Heslop, M K Brenner, et al.
Clinical and Experimental Immunology|June 15, 2013
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapyC R Y Cruz, S Lam, P J Hanley, et al.
Pediatric Hematology and Oncology|May 29, 2012
Pediatric Hodgkin lymphoma: are we over-scanning our patients?N Rathore, H M Eissa, J F Margolin, et al.
Pageof 2